cefuroxime has been researched along with Neoplasms in 4 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this investigation was to assess retrospectively the safety and the efficacy of oral ciprofloxacin plus cefuroxime axetil compared to the combination of oral ciprofloxacin plus amoxicillin/clavulanate, as initial outpatient treatment, in low-risk cancer patients with fever and neutropenia." | 7.74 | Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. ( Karabelis, A; Kordossis, T; Kosmas, C; Sipsas, NV; Skopelitis, E; Tsavaris, N; Vadiaka, M; Ziakas, PD, 2007) |
| "The objective of this investigation was to assess retrospectively the safety and the efficacy of oral ciprofloxacin plus cefuroxime axetil compared to the combination of oral ciprofloxacin plus amoxicillin/clavulanate, as initial outpatient treatment, in low-risk cancer patients with fever and neutropenia." | 3.74 | Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. ( Karabelis, A; Kordossis, T; Kosmas, C; Sipsas, NV; Skopelitis, E; Tsavaris, N; Vadiaka, M; Ziakas, PD, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sipsas, NV | 1 |
| Kosmas, C | 1 |
| Ziakas, PD | 1 |
| Karabelis, A | 1 |
| Vadiaka, M | 1 |
| Skopelitis, E | 1 |
| Kordossis, T | 1 |
| Tsavaris, N | 1 |
| Azzoni, P | 1 |
| Sortini, A | 1 |
| Di Marco, L | 1 |
| Navarra, G | 1 |
| Donini, A | 1 |
| Fiorentini, G | 1 |
| Santini, M | 1 |
| Sartori, A | 1 |
| Donini, I | 1 |
| Wilkinson, TJ | 1 |
| Robinson, BA | 1 |
1 trial available for cefuroxime and Neoplasms
| Article | Year |
|---|---|
[Treatment with immunomodulating drugs of patients with operated cancer. Long-term results].
Topics: Adjuvants, Immunologic; Cefuroxime; Follow-Up Studies; Humans; Interferon Inducers; Neoplasms; Posto | 1994 |
3 other studies available for cefuroxime and Neoplasms
| Article | Year |
|---|---|
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; A | 2007 |
[Cefuroxime-tobramycin treatment of bacterial infections in cancer patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Therapy, Combination; | 1980 |
Neutropenic sepsis complicating treatment of solid tumours, lymphoma and myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cefuroxime; Drug Therapy, Comb | 1992 |